Nitazoxanide: UMED completed enrollment in a 28-patient Phase II trial.

Unimed Pharmaceuticals Inc. (UMED), Buffalo Grove, Ill. Product: Nitazoxanide (NTZ) Indication: Cryptosporidiosis infection in AIDS patients Status: UMED completed enrollment in a 28-patient Phase II ...